Pernix Therapeutics (NASDAQ: PTX) announced the completion of a new three-year $50 million revolving credit facility with Wells Fargo. The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE